Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.72%
#2 Ocean Protocol Ocean Protocol +18.39%
#3 Audiera Audiera +12.88%
#4 Cysic Cysic +12.35%
#5 KUB Coin KUB Coin +12.19%
#6 Geodnet Geodnet +11.47%
#7 Perle Perle +8.62%
#8 Wiki Cat Wiki Cat +8.49%
#9 Quack AI Quack AI +8.27%
#10 DexNet DexNet +7.78%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
MapLight Therapeutics, Inc. MapLight Therapeutics, Inc.

MapLight Therapeutics, Inc.

MPLT
Kedudukan dalam Saham #32258
MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical firm... MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for individuals grappling with severe central nervous system (CNS) disorders. Its pipeline features several promising therapeutic candidates: ML-007C-MA, a fixed-dose combination of an M1/M4 muscarinic agonist, is being advanced to address symptoms of schizophrenia and Alzheimer's disease psychosis. Additionally, the company is investigating ML-004 for its potential to alleviate social communication deficits and irritability associated with autism spectrum disorder, while ML-021 is designed to target motor impairments seen in Parkinson's disease. Furthermore, ML-009, a G-protein-coupled receptor 52 positive allosteric modulator, is under development for conditions involving hyperactivity, impulsivity, and agitation. Beyond its drug portfolio, MapLight has also established a proprietary platform focused on identifying neural circuits fundamentally linked to disease and then precisely modulating these circuits for therapeutic benefit. Established in 2018 under its former name, Alvarado Therapeutics, Inc., the company adopted the MapLight Therapeutics, Inc. identity in August 2019. Based in Redwood City, California, it operates as a subsidiary of Catalyst4, Inc.
Harga Saham
$13.43
Disegerakkan terakhir: 2026-07-31
Modal Pasaran
$10.60M
Perubahan (1 hari)
-4.26%
Perubahan (1 tahun)
-
Negara
US
Perdagangan MapLight Therapeutics, Inc. (MPLT)

Kategori

Healthcare
Sejarah harga saham bagi MapLight Therapeutics, Inc. (MPLT)
Harga penutupan tertinggi: $31.59 pada 2026-07-01

Harga penutupan terendah: $17.39 pada 2025-10-01
Sejarah harga saham MapLight Therapeutics, Inc. dari 2025 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 22.89%
2025 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $515.58 32.24%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $992.01 50.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $110.17 -37.47%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.64 6.99%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.06K -6.61%
KR